MEKK1 Antibody [B14N1] | Primary Antibodies

Application: Reactivity: Mouse, Rat, Human

Usage Information

Dilution
WB1:100-1:1000 IF1:50-1:500

Application
WB, IP, IF

Reactivity
Mouse, Rat, Human

Source
Mouse Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
164 kDa 195 kDa, 80 kDa
^*Why do the predicted and actual molecular weights differ? The following reasons may explain differences between the predicted and actual protein molecular weight. Post-translational modifications(e.g., phosphorylation, glycosylation); Splice variants and isoforms; Relative charge; Multimerization.

Datasheet & SDS

Biological Description

Specificity
MEKK1 Antibody [B14N1] detects endogenous levels of total MEKK1 protein.

Clone
B14N1

Synonym(s)
Mitogen-activated protein kinase kinase kinase 1, MAPK/ERK kinase kinase 1 (MEK kinase 1; MEKK 1), MAP3K1, MAPKKK1, MEKK, MEKK1

Background
MEKK1, also termed MAP3K1, is a MAP kinase kinase kinase that links receptors for growth factors, cytokines, and stress signals to downstream MAPK and NF‑κB pathways through its dual functions as a serine/threonine protein kinase and a RING/PHD‑type E3 ubiquitin ligase. The protein contains an N‑terminal regulatory and scaffold region with multiple docking motifs, a central plant homeodomain (PHD) finger with RING‑like E3 ligase activity, and a C‑terminal kinase domain that phosphorylates specific MAP2Ks, including MEK1/2 (MAP2K1/2) and MKK4/7 (MAP2K4/7), which in turn activate ERK1/2 and JNK MAPKs. MEKK1 associates with upstream adaptors such as TRAF2, Grb2, and small GTPases and is recruited to receptor complexes downstream of TNF receptor family members, T‑cell receptor, EGFR, and TGFβ receptors; within these complexes, MEKK1 functions as both a scaffold and a catalytic kinase that organizes and activates ERK and JNK cascades in response to mitogenic and stress signals. The kinase also contributes to NF‑κB pathway activation by phosphorylating components upstream of the IKK complex and by participating in signaling to AP‑1 and NF‑κB transcription factors under conditions such as TNFα stimulation and osmotic or cytoskeletal stress. The PHD/RING domain of MEKK1 acts as an E3 ligase that interacts with ubiquitin‑conjugating enzymes, including UBE2D family members and UBE2N complexes, and catalyzes ubiquitination of substrates such as c‑Jun and other signaling proteins, which modulates their stability and activity and is required together with the kinase domain for full MAPK activation. MEKK1 is proteolytically cleaved by caspases during Fas‑ and stress‑induced apoptosis, generating an active kinase fragment that translocates and amplifies JNK and stress‑activated pathway signaling, linking caspase activation to MAPK‑driven apoptotic programs. MEKK1 regulates cell survival during hyperosmotic and microtubule-disrupting stress. MEKK1 also controls C/EBPβ-dependent transcription in response to interferon-γ and represses promoters like PKD1 through interactions with promoter-bound p53.

Background

MEKK1, also termed MAP3K1, is a MAP kinase kinase kinase that links receptors for growth factors, cytokines, and stress signals to downstream MAPK and NF‑κB pathways through its dual functions as a serine/threonine protein kinase and a RING/PHD‑type E3 ubiquitin ligase. The protein contains an N‑terminal regulatory and scaffold region with multiple docking motifs, a central plant homeodomain (PHD) finger with RING‑like E3 ligase activity, and a C‑terminal kinase domain that phosphorylates specific MAP2Ks, including MEK1/2 (MAP2K1/2) and MKK4/7 (MAP2K4/7), which in turn activate ERK1/2 and JNK MAPKs. MEKK1 associates with upstream adaptors such as TRAF2, Grb2, and small GTPases and is recruited to receptor complexes downstream of TNF receptor family members, T‑cell receptor, EGFR, and TGFβ receptors; within these complexes, MEKK1 functions as both a scaffold and a catalytic kinase that organizes and activates ERK and JNK cascades in response to mitogenic and stress signals. The kinase also contributes to NF‑κB pathway activation by phosphorylating components upstream of the IKK complex and by participating in signaling to AP‑1 and NF‑κB transcription factors under conditions such as TNFα stimulation and osmotic or cytoskeletal stress. The PHD/RING domain of MEKK1 acts as an E3 ligase that interacts with ubiquitin‑conjugating enzymes, including UBE2D family members and UBE2N complexes, and catalyzes ubiquitination of substrates such as c‑Jun and other signaling proteins, which modulates their stability and activity and is required together with the kinase domain for full MAPK activation. MEKK1 is proteolytically cleaved by caspases during Fas‑ and stress‑induced apoptosis, generating an active kinase fragment that translocates and amplifies JNK and stress‑activated pathway signaling, linking caspase activation to MAPK‑driven apoptotic programs. MEKK1 regulates cell survival during hyperosmotic and microtubule-disrupting stress. MEKK1 also controls C/EBPβ-dependent transcription in response to interferon-γ and represses promoters like PKD1 through interactions with promoter-bound p53.

References
https://pubmed.ncbi.nlm.nih.gov/9836645/ https://pubmed.ncbi.nlm.nih.gov/9689033/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%